Literature DB >> 23243311

Crystal structures of the DNA-binding domain tetramer of the p53 tumor suppressor family member p73 bound to different full-site response elements.

Abdul S Ethayathulla1, H Thien Nguyen, Hector Viadiu.   

Abstract

How cells choose between developmental pathways remains a fundamental biological question. In the case of the p53 protein family, its three transcription factors (p73, p63, and p53) each trigger a gene expression pattern that leads to specific cellular pathways. At the same time, these transcription factors recognize the same response element (RE) consensus sequences, and their transactivation of target genes overlaps. We aimed to understand target gene selectivity at the molecular level by determining the crystal structures of the p73 DNA-binding domain (DBD) in complex with full-site REs that vary in sequence. We report two structures of the p73 DBD bound as a tetramer to 20-bp full-site REs based on two distinct quarter-sites: GAACA and GAACC. Our study confirms that the DNA-binding residues are conserved within the p53 family, whereas the dimerization and tetramerization interfaces diverge. Moreover, a conserved lysine residue in loop L1 of the DBD senses the presence of guanines in positions 2 and 3 of the quarter-site RE, whereas a conserved arginine in loop 3 adapts to changes in position 5. Sequence variations in the RE elicit a p73 conformational response that might explain target gene specificity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23243311      PMCID: PMC3576079          DOI: 10.1074/jbc.M112.408039

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  Structure and function in the p53 family.

Authors:  C H Arrowsmith
Journal:  Cell Death Differ       Date:  1999-12       Impact factor: 15.828

2.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.

Authors:  A Yang; R Schweitzer; D Sun; M Kaghad; N Walker; R T Bronson; C Tabin; A Sharpe; D Caput; C Crum; F McKeon
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

3.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.

Authors:  Elsa R Flores; Kenneth Y Tsai; Denise Crowley; Shomit Sengupta; Annie Yang; Frank McKeon; Tyler Jacks
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

4.  p63 is a p53 homologue required for limb and epidermal morphogenesis.

Authors:  A A Mills; B Zheng; X J Wang; H Vogel; D R Roop; A Bradley
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

5.  Macromolecular TLS refinement in REFMAC at moderate resolutions.

Authors:  Martyn D Winn; Garib N Murshudov; Miroslav Z Papiz
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

6.  p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours.

Authors:  A Yang; N Walker; R Bronson; M Kaghad; M Oosterwegel; J Bonnin; C Vagner; H Bonnet; P Dikkes; A Sharpe; F McKeon; D Caput
Journal:  Nature       Date:  2000-03-02       Impact factor: 49.962

Review 7.  On the shoulders of giants: p63, p73 and the rise of p53.

Authors:  Annie Yang; Mourad Kaghad; Daniel Caput; Frank McKeon
Journal:  Trends Genet       Date:  2002-02       Impact factor: 11.639

8.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling.

Authors:  P Schuck
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

9.  Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo.

Authors:  Jianyuan Luo; Muyang Li; Yi Tang; Monika Laszkowska; Robert G Roeder; Wei Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

Review 10.  The p53/p63/p73 family of transcription factors: overlapping and distinct functions.

Authors:  M Levrero; V De Laurenzi; A Costanzo; J Gong; J Y Wang; G Melino
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

View more
  9 in total

1.  Evolution of p53 transactivation specificity through the lens of a yeast-based functional assay.

Authors:  Mattia Lion; Ivan Raimondi; Stefano Donati; Olivier Jousson; Yari Ciribilli; Alberto Inga
Journal:  PLoS One       Date:  2015-02-10       Impact factor: 3.240

Review 2.  p53 Family and Cellular Stress Responses in Cancer.

Authors:  Johanna Pflaum; Sophie Schlosser; Martina Müller
Journal:  Front Oncol       Date:  2014-10-21       Impact factor: 6.244

3.  ∆N-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites.

Authors:  Paola Monti; Yari Ciribilli; Alessandra Bisio; Giorgia Foggetti; Ivan Raimondi; Paola Campomenosi; Paola Menichini; Gilberto Fronza; Alberto Inga
Journal:  Oncotarget       Date:  2014-04-30

4.  Quantification of Cooperativity in Heterodimer-DNA Binding Improves the Accuracy of Binding Specificity Models.

Authors:  Alina Isakova; Yves Berset; Vassily Hatzimanikatis; Bart Deplancke
Journal:  J Biol Chem       Date:  2016-02-24       Impact factor: 5.157

5.  Defining TP53 pioneering capabilities with competitive nucleosome binding assays.

Authors:  Xinyang Yu; Michael J Buck
Journal:  Genome Res       Date:  2018-11-08       Impact factor: 9.043

Review 6.  Structural diversity of p63 and p73 isoforms.

Authors:  Christian Osterburg; Volker Dötsch
Journal:  Cell Death Differ       Date:  2022-03-21       Impact factor: 12.067

7.  Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code.

Authors:  Yari Ciribilli; Paola Monti; Alessandra Bisio; H Thien Nguyen; Abdul S Ethayathulla; Ana Ramos; Giorgia Foggetti; Paola Menichini; Daniel Menendez; Michael A Resnick; Hector Viadiu; Gilberto Fronza; Alberto Inga
Journal:  Nucleic Acids Res       Date:  2013-07-26       Impact factor: 16.971

8.  Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer.

Authors:  Jialing Zhang; Bin Yan; Stephan Stanislaw Späth; Hu Qun; Shaleeka Cornelius; Daogang Guan; Jiaofang Shao; Koichi Hagiwara; Carter Van Waes; Zhong Chen; Xiulan Su; Yongyi Bi
Journal:  Cell Biosci       Date:  2015-09-17       Impact factor: 7.133

9.  MCL1 binds and negatively regulates the transcriptional function of tumor suppressor p73.

Authors:  Hayley Widden; Aneta Kaczmarczyk; Ashok Subedi; Robert H Whitaker; William J Placzek
Journal:  Cell Death Dis       Date:  2020-11-03       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.